The genes and proteins associated with polycystic kidney diseases

Minerva Urologica e Nefrologica

Volumn 54, Issue 4, 2002, Pages 201-211

  Wilson, P D ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Polycystic kidney diseases, diagnosis; Polycystic kidney diseases, genetics; Proteins

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROCYSTIN; ISOPROTEIN; NEPHROCYSTIN; POLYCYSTIN; PROTEIN; UNCLASSIFIED DRUG;

AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL RECESSIVE DISORDER; CELL ADHESION; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CYTOPATHOLOGY; DISEASE ASSOCIATION; EPITHELIUM CELL; FOCAL ADHESION; GENE FUNCTION; GENETIC CODE; HUMAN; KIDNEY POLYCYSTIC DISEASE; KIDNEY TUBULE; MORPHOGENESIS; MUTATIONAL ANALYSIS; PATHOGENESIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

DNA MUTATIONAL ANALYSIS; HUMANS; MEMBRANE PROTEINS; POLYCYSTIC KIDNEY DISEASES; PROTEINS; TRPP CATION CHANNELS;

EID: 0036923662     PISSN: 03932249     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. Dalgaard OZ. Bilateral polycystic disease of the kidneys: a follow-up study of 284 patients and their families. Acta Med Scand 1957;158:1.
2. Gabow PA, Ikle DW, Holmes JH. Polycystic kidney disease: prospective analysis of nonazotemic patients and family members. Ann Intern Med 1984;101:238-47.
3. Reeders ST, Keith T, Green P, Germino GG, Barton NJ, Lehmann OJ et al. Regional localization of the autosomal dominant polycystic kidney disease locus. Genomics 1988;3:150-5.
4. Kimberling WJ, Fain PR, Kenyon JB, Goldgar D, Sujansky E, Gabow PA. Linkage heterogeneity of autosomal dominant polycystic kidney disease. N Engl J Med 1988;319:913-8.
5. Kimberling WJ, Kuman S, Gabow PA. Identification of chromosome site of autosomal dominant polycystic kidney disease unlinked to chromosome 16. J Am Soc Nephrol 1993;4:816.
6. Consortium T.E.K.D. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. [published errata appear in Cell 1994;78:following 724 and 1995 Jun 30;81:following 1170]. Cell 1994;77:881-94.
7. Kimura F, Shen Y, Date S, Azemoto S, Mochizuki T. Thoracic aortic aneurysm and aortic dissection: new endoscopic mode for three-dimensional CT display of aorta. Radiology 1996;198:573-8.
8. Sedman A, Bell P, Manco-Johnson M, Schrier R, Warady BA, Heard EO et al. Autosomal dominant polycystic kidney disease in childhood: a longitudinal study. Kidney Int 1987;31:1000-5.
9. Parfrey PS, Bear JC, Morgan J, Cramer BC, McManamon PJ, Gault MH et al. The diagnosis and prognosis of autosomal dominant polycystic kidney disease. N Engl J Med 1990;323:1085-90.
10. Zerres K, Rudnik-Schoneborn S, Steinkamm C, Mucher G. Autosomal recessive polycystic kidney disease. Nephrol Dial Transplant 1996;11 Suppl 6:29-33.
11. Ward CJ, Hogan MC, Rossetti S, Walker D, Sneddon T, Wang X et al. The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat Genet 2002;30:259-69.
12. Antignac C, Arduy CH, Beckmann JS, Benessy F, Gros F, Medhioub M et al. A gene for familial juvenile nephronophthisis (recessive medullary cystic kidney disease) maps to chromosome 2p. Nat Genet 1993;3:342-5.
13. Hildebrandt F, Otto E, Rensing C, Nothwang HG, Vollmer M, Adolphs J et al. A novel gene encoding an SH3 domain protein is mutated in nephronophthisis type 1. Nat Genet 1997;17:149-53.
14. Hildebrandt F, Otto E. Molecular genetics of nephronophthisis and medullary cystic kidney disease. J Am Soc Nephrol 2000;11:1753-61.
15. Omran H, Haffner K, Burth S, Fernandez C, Fargier B, Villaquiran A et al. Human adolescent nephronophthisis: gene locus synteny with polycystic kidney disease in pcy mice. J Am Soc Nephrol 2001;12:107-13.
16. Hateboer N, Gumbs C, Teare MD, Coles GA, Griffiths D, Ravine D et al. Confirmation of a gene locus for medullary cystic kidney disease (MCKD2) on chromosome 16p12. Kidney Int 2001;60:1233-9.
17. Fuchshuber A, Kroiss S, Karle S, Berthold S, Huck K, Burton C et al. Refinement of the gene locus for autosomal dominant medullary cystic kidney disease type 1 (MCKD1) and construction of a physical and partial transcriptional map of the region. Genomics 2001;72:278-84.
18. Cotran RS, Kumar V, Collins T. Pathologic basis of disease. 6th ed. Philadelphia: W.B. Saunders; 1999.
19. th ed. Philadelphia: Lippincott-Raven; 1998.
20. Phakdeekitcharoen B, Watnick TJ, Ahn C, Whang DY, Burkhart B, Germino GG. Thirteen novel mutations of the replicated region of PKD1 in an Asian population. Kidney Int 2000;58:1400-12.
21. Thomas R, McConnell R, Whittacker J, Kirkpatrick P, Bradley J, Sandford R. Identification of mutations in the repeated part of the autosomal dominant polycystic kidney disease type 1 gene, PKD1, by long-range PCR. Am J Hum Genet 1999;65:39-49.
22. Peters DJ, Breuning MH Autosomal dominant polycystic kidney disease: modification of disease progression. Lancet 2001;358:1439-44.
23. Peral B, Gamble V, San Millan JL, Strong C, Sloane-Stanley J, Moreno F et al. Splicing mutations of the polycystic kidney disease 1 (PKD1) gene induced by intronic deletion. Hum Mol Genet 1995;4:569-74.
24. Brook-Carter PT, Peral B, Ward CJ, Thompson P, Hughes J, Maheshwar MM et al. Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease: a contiguous gene syndrome. Nat Genet 1994;8:328-32.
25. Kuida S, Beier DR. Genetic localization of interacting modifiers affecting severity in a murine model of polycystic kidney disease. Genome Res 2000;10:49-54.
26. Sommardahl C, Cottrell M, Wilkinson JE, Woychik RP, Johnson DK. Phenotypic variations of orpk mutation and chromosomal localization of modifiers influencing kidney phenotype. Physiol Genomics 2001;7:127-34.
27. Woo DD, Nguyen DK, Khatibi N, Olsen P. Genetic identification of 2 major modifier loci of polycystic kidney disease progression in pcy mice. J Clin Invest 1997;100:1934-40.
28. Wilson PD. Pathogenesis of polycystic kidney disease: altered cellular function. In: Watson M, Torres V, editors. Oxford: Oxford University Press; 1995. p. 125-63.
29. Wilson PD. Polycystin: new aspects of structure, function, and regulation. J Am Soc Nephrol 2001;12:834-45.
30. Wilson PD, Du J, Norman JT. Autocrine, endocrine and paracrine regulation of growth abnormalities in autosomal dominant kidney disease. Eur J Cell Biol 1993;61:131-8.
31. Du J, Wilson PD. Abnormal polarization of EGF receptors and autocrine stimulation of cyst epithelial growth in human ADPKD. Am J Physiol 1995;269(2 Pt 1):C487-95.
32. Wilson PD, Falkenstein D. The pathology of human renal cystic disease. In: Dodd SM, editor. Current topics in pathology. Heidelberg: Springer-Verlag; 1995. p. 1-50.
33. Sweeney WE Jr, Avner ED. Functional activity of epidermal growth factor receptors in autosomal recessive polycystic kidney disease. Am J Physiol 1998;275(3 Pt 2):F387-94.
34. Wilson SJ. A role for erb-B2 in apical membrane polarization of EGF receptors in fetal and polycystic kidney disease epithelia. Nat Med 2002. In press.
35. Wilson PD. Aberrant epithelial cell growth in autosomal dominant polycystic kidney disease. Am J Kid Dis 1991;26:634-7.
36. Wilson PD, Devuyst O, Li X, Gatti L, Falkenstein D, Robinson S et al. Apical plasma membrane mispolarization of NaK-ATPase in polycystic kidney disease epithelia is associated with aberrant expression of the β2 isoform. Am J Pathol 2000;156:253-68.
37. Devuyst O, Golstein PE, Sanches MV, Piontek K, Wilson PD, Guggino WB et al. Expression of CFTR in human and bovine thyroid epithelium. Am J Physiol 1997;272(4 Pt 1):C1299-308.
38. Hanaoka K, Devuyst O, Schwiebert EM, Wilson PD, Guggino WB. A role for CFTR in human autosomal dominant polycystic kidney disease. Am J Physiol 1996;270(1 Pt 1):C389-99
39. Winyard PJ, Risdon RA, Sams VR, Dressler GR, Woolf AS. The PAX2 tanscription factor is expressed in cystic and hyperproliferative dysplastic epithelia in human kidney malformations. J Clin Invest 1996;98:451-9.
40. Wilson PD, Hreniuk D, Gabow PA. Abnormal extracellular matrix and excessive growth of human adult polycystic kidney disease epithelia. J Cell Physiol 1992;150:360-9.
41. Ekblom P. Genetics of kidney development. Curr Opin Nephrol Hypertens 1996;5:282-7.
42. Burrow CR. Regulatory molecules in kidney development. Pediatr Nephrol 2000;14:240-53.
43. Hughes J, Ward CJ, Peral B, Aspinwall R, Clark K, San Millan JL. et al. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet 1995;10:151-60.
44. Consortium T.I.P.K.D. Polycystic kidney disease: the complete structure of the PKD1 gene and its protein. Cell 1995;81:289-98.
45. Weston BS, Bagneris C, Price RG, Stirling JL. The polycystin-1 C-type lectin domain binds carbohydrate in a calcium-dependent manner, and interacts with extracellular matrix proteins in vitro. Biochim Biophys Acta 2001;1536:161-76.
46. Malhas AN, Abuknesha RA, Price RG. Interaction of the leucine-rich repeats of polycystin-1 with extracellular matrix proteins: possible role in cell proliferation. J Am Soc Nephrol 2002;13:19-26.
47. Bycroft M, Bateman A, Clarke J, Hamill SJ, Sandford R, Thomas RL et al. The structure of a PKD domain from polycystin-1: implications for polycystic kidney disease. EMBO J 1999;18:297-305.
48. Moy GW, Mendoza LM, Schulz JR, Swanson WJ, Glabe CG, Vacquier VD. The sea urchin sperm receptor for egg jelly is a modular protein with extensive homology to the human polycystic kidney disease protein, PKD1. J Cell Biol 1996;133:809-17.
49. Li HP, Geng L, Burrow CR, Wilson PD. Identification of phosphorilation sites in the PKD1-encoded protein C-terminal domain. Biochem Biophys Res Commun 1999;259:356-63.
50. Li X, Li HP, Amsler K, Hyink D, Wilson PD, Burrow CR. PRKX, a phylogenetically and functionally distinct cAMP-dependent protein kinase, activates renal epithelial cell migration and morphogenesis. Proc Natl Acad Sci USA 2002;99:9260-5.
51. Parnell SC, Magenheimer BS, Maser RL, Rankin CA, Smine A, Okamoto T et al. The polycystic kidney disease-1 protein, polycystin-1, binds and activates heterotrimeric G-proteins in vitro. Biochem Biophys Res Commun 1998;251:625-31.
52. Qian F, Germino FJ, Cai Y, Zhang X, Somlo S, Germino GG. PKD1 interacts with PKD2 through a probable coiled-coil domain. Nat Genet 1997;16:179-83.
53. Tsiokas L, Kim E, Arnould T, Sukhatme VP, Walz G. Homo- and heterodimeric interactions between the gene products of PKD1 and PKD2. Proc Natl Acad Sci USA 1997;94:6965-70.
54. Ward CJ, Turley H, Ong AC, Comley M, Biddolph S, Chetty R et al. Polycystin, the polycystic kidney disease 1 protein, is expressed by epithelial cells in fetal, adult, and polycystic kidney. Proc Natl Acad Sci USA 1996;93:1524-8.
55. Geng L, Segal Y, Peissel B, Deng N, Pei Y, Carone F et al. Identification and localization of polycystin, the PKD1 gene product. J Clin Invest 1996;98:2674-82.
56. Van Adelsberg J, Chamberlain S, D'Agati V. Polycystin expression is temporally and spatially regulated during renal development. Am J Physiol 1997;272:F602-9.
57. Wilson PD. Epithelial cell polarity and disease. Am J Physiol 1997;272(4 Pt 2):F434-42.
58. Wilson PD, Geng L, Li X, Burrow CR. The PKD1 gene product, "polycystin-1", is a tyrosine-phosphorylated protein that colocalizes with α2β1-integrin in focal clusters in adherent renal epithelia. Lab Invest 1999;79:1311-23.
59. Geng L, Burrow CR, Li HP, Wilson PD. Modification of the composition of polycystin-1 multiprotein complexes by calcium and tyrosine phosphorylation. Biochim Biophys Acta 2000;1535:21-35.
60. Illc D et al. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 1995;377:539-43.
61. Huan Y, van Adelsberg J. Polycystin-1, the PKD1 gene product, is in a complex containing E-cadherin and the catenins. J Clin Invest 1999;104:1459-68.
62. Tsiokas L, Arnould T, Zhu C, Kim E, Walz G, Sukhatme VP. Specific association of the gene product of PKD2 with the TRPC1 channel. Proc Natl Acad Sci USA 1999;96:3934-9.
63. Hanaoka K, Quan F, Boletta A, Bhunia AR, Piontek K, Tsiokas L et al. Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents. Nature 2000;408:990-4.
64. Gonzalez-Perrett S, Kim K, Iborra C, Damiano AE, Zotta E, Batelli M et al. Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2+-permeable nonselective cation channel. Proc Natl Acad Sci USA 2001;98:1182-7.
65. Koulen P, Cai Y, Geng L, Maeda Y, Nishimura S, Witzgall R et al. Polycystin-2 is an intracellular calcium release channel. Nat Cell Biol 2002;4:191-7.
66. Arnould T, Kim E, Tsiokas L, Jochimsen F, Gruning W, Chang JD et al. The polycystic kidney disease 1 gene product mediates protein kinase C α-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1. J Biol Chem 1998;273:6013-8
67. Kim E, Arnould T, Sellin LK, Benzing T, Fan MJ, Gruning W et al. The polycystic kidney disease 1 gene product modulates Wnt signaling. J Biol Chem 1999;274:4947-53.
68. Parnell SC, Magenheimer BS, Maser RL, Zien CA, Frischauf AM, Calvet JP. Polycystin-1 activation of c-Jun N-terminal kinase and AP-1 is mediated by heterotrimeric G proteins. J Biol Chem 2002;277:19566-72.
69. Arnould T, Sellin L, Benzing T, Tsiokas L, Cohen HT, Kim E et al. Cellular activation triggered by the autosomal dominant polycystic kidney disease gene product PKD2. Mol Cell Biol 1999;19:3423-34.
70. Bhunia AK, Piontek K, Boletta A, Liu L, Qian F, Xu PN et al. PKD1 induces p21(waf1) and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2. Cell 2002;109:157-68.
71. Delmas P, Nomura H, Li X, Lakkis M, Luo Y, Segal Y et al. Constitutive activation of G-proteins by polycystin-1 is antagonized by polycystin-2. J Biol Chem 2002;277:11276-83.
72. Hyink D et al. Reversal of the ADPKD epithelial cell decreased motility phenotype by lithium. J Am Soc Nephrol 2000;11:392A.